Zhang J, Silverberg JI, Guo J, Yun J, et al. Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized, phase II trial (SEASIDE CHINA): initial two-week dosing, followed by two-week or four-week dosing. Br J Dermatol 2025 Sep 2:ljaf347. doi: 10.1093.
PMID: 40892481